Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals

Author： Okamoto H.   Iwamoto Y.   Maki M.   Sotani T.   Yonemori F.   Wakitani K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.466, Iss.1, 2003-04, pp. : 147-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-04 ,pp. : 257-264

Bentham Science Publishers

Access to resources Recommend Favorite

Assessing Lipid Lowering and Plasma Cholesteryl Ester Transfer Protein Activity of Simvastatin Following Administration to Rabbits Fed a High Fat/Cholesterol Diet

By Risovic Verica   Man Damen   Sivak Olena   Lee Stephen   Wasan Kishor  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 5, 2006-07 ,pp. : 609-615

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Dalcetrapib, a cholesteryl ester transfer protein modulator

By Hooper Amanda J   Burnett John R  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1427-1432

Informa Healthcare

Access to resources Recommend Favorite

Anacetrapib, a cholesteryl ester transfer protein inhibitor

By Hooper Amanda J   Burnett John R  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite